Federal Register / Vol. 70, No.
65 / Wednesday, April 6, 2005 / Notices
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than May 6, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6786 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 8,
2005, Polaroid Corporation, 1265 Main
Street, Building W6, Waltham,
Massachusetts 02454, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of 2,5-
Dimethoxyamphetamine (7396), a basic
class of controlled substance listed in
Schedule I.
VerDate jul<14>2003 18:17 Apr 05, 2005 Jkt 205001
17473
The company plans to manufacture DEPARTMENT OF JUSTICE
the listed controlled substance in bulk
for conversion into non-controlled Drug Enforcement Administration
substances.
Importer of Controlled Substances;
Any other such applicant and any Notice of Application
person who is presently registered with
Pursuant to 21 U.S.C. 958(i), the
DEA to manufacture such a substance
Attorney General shall, prior to issuing
may file comments or objections to the
issuance of the proposed registration a registration under this Section to a
bulk manufacturer of a controlled
pursuant to 21 CFR 1301.33(a).
substance in Schedule I or II and prior
Any such written comments or to issuing a regulation under 21 U.S.C.
objections being sent via regular mail 952(a)(2)(B) authorizing the importation
may be addressed, in quintuplicate, to of such a substance, provide
the Deputy Assistant Administrator, manufacturers holding registrations for
Office of Diversion Control, Drug the bulk manufacture of the substance
Enforcement Administration, an opportunity for a hearing.
Washington, DC 20537, Attention: DEA Therefore, in accordance with 21 CFR
Federal Register Representative, Liaison 1301.34(a), this is notice that on January
and Policy Section (ODL); or any being 7, 2005, Sigma Aldrich Company,
sent via express mail should be sent to Subsidiary of Sigma-Aldrich
DEA Headquarters, Attention: DEA Corporation, 3500 Dekalb Street, St.
Louis, Missouri 63118, made
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway, application by renewal to the Drug
Enforcement Administration (DEA) to
Alexandria, Virginia 22301; and must be
filed no later than June 6, 2005. be registered as an importer of the basic
classes of controlled substances listed in
Dated: March 29, 2005. Schedule I and II:
William J. Walker,
Deputy Assistant Administrator, Office of Drug Schedule
Diversion Control, Drug Enforcement
Cathinone (1235) .......................... I
Administration.
Methcathinone (1237) .................. I
[FR Doc. 05–6799 Filed 4–5–05; 8:45 am] Aminorex (1585) ........................... I
BILLING CODE 4410–09–P Gamma Hydroxybutyric Acid I
(2010).
Methaqualone (2565) ................... I
Ibogaine (7260) ............................ I
DEPARTMENT OF JUSTICE
Lysergic acid diethylamide (7315) I
Mescaline (7381) .......................... I
Drug Enforcement Administration 4-Bromo-2,5-dimethoxy-amphet- I
amine (7391).
Manufacturer of Controlled 4-Bromo-2,5- I
Substances; Notice of Application; dimethoxyphenethylamine
Correction (7392).
2,5-Dimethoxyamphetamine I
By notice dated February 23, 2005, (7396).
and published in the Federal Register 3,4-Methylenedioxyamphetamine I
(7400).
on March 4, 2005 (70 FR 10683), the
N-Hydroxy-3,4- I
listing of controlled substances methylenedioxyamphetamine
Oxycodone (9143) and Morphine (9300), (7402).
were inadvertently omitted, for 3,4-Methylenedioxy-N- I
Siegfried (USA), Inc., Industrial Park ethylamphetamine (7404).
Road, Pennsville, New Jersey 08070. 3,4- I
Methylenedioxymethamphetam-
The Notice of Application should be
ine (MDMA) (7405).
corrected to include Oxycodone (9143) 4-Methoxyamphetamine (7411) ... I
and Morphine (9300). Bufotenine (7433) ......................... I
Dated: March 29, 2005. Psilocyn (7438) ............................. I
Benzylpiperazine (BZP) (7493) .... I
William J. Walker, 1-(alpha, alpha, alpha-trifluoro-m- I
Deputy Assistant Administrator, Office of tolyl) Piperazine (TEMPP)
Diversion Control, Drug Enforcement (7494).
Administration. Heroin (9200) ............................... I
[FR Doc. 05–6791 Filed 4–5–05; 8:45 am] Normorphine (9313) ..................... I
Etonitazene (9624) ....................... I
BILLING CODE 4410–09–P
Amphetamine (1100) .................... II
Methamphetamine (1105) ............ II
Methylphenidate (1724) ................ II
Amobarbital (2125) ....................... II
Pentobarbital (2270) ..................... II
Secobarbital (2315) ...................... II
PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1